{
  "trial_id": "NCT01618214",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Duration of Type 2 Diabetes, Current Insulin Dose, HbA1c, Body Mass Index (BMI), Use of Metformin, Use of Alpha-glucosidase Inhibitors, Total Daily Insulin Dose",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Gender"
        ],
        [
          "Body mass index (BMI)",
          "Body Mass Index (BMI)"
        ],
        [
          "Glycosylated Haemoglobin (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Weight",
        "Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Duration of Type 2 Diabetes",
        "Current Insulin Dose",
        "Use of Metformin",
        "Use of Alpha-glucosidase Inhibitors",
        "Total Daily Insulin Dose"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Total Daily Insulin Dose, Use of Oral Antidiabetic Drugs, Systolic Blood Pressure, Diastolic Blood Pressure,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "Sex: Female"
        ],
        [
          "Body mass index (BMI)",
          "Body Mass Index"
        ],
        [
          "Glycosylated Haemoglobin (HbA1c)",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Race (NIH/OMB)",
        "Weight",
        "Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of Diabetes",
        "Total Daily Insulin Dose",
        "Use of Oral Antidiabetic Drugs",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Region of Enrollment, Diabetes Duration, Body Mass Index, HbA1c, Total Daily Insulin Dose, Metformin Dose, Alpha-glucosidase Inhibitor Dose.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Body mass index (BMI)",
          "Body Mass Index"
        ],
        [
          "Glycosylated Haemoglobin (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Gender",
        "Race (NIH/OMB)",
        "Weight",
        "Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "Sex: Female",
        "Male",
        "Region of Enrollment",
        "Diabetes Duration",
        "Total Daily Insulin Dose",
        "Metformin Dose",
        "Alpha-glucosidase Inhibitor Dose"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetes, HbA1c, total daily insulin dose, type of oral antidiabetic drugs (OADs) used, metformin dose, alpha-glucosidase inhibitor dose, smoking status, systolic blood pressure, diastolic blood pressure, history of hypoglycaemia, history of diabetic complications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Gender",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Body mass index (BMI)",
          "body mass index (BMI)"
        ],
        [
          "Glycosylated Haemoglobin (HbA1c)",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Weight",
        "Fasting Plasma Glucose"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "duration of diabetes",
        "total daily insulin dose",
        "type of oral antidiabetic drugs (OADs) used",
        "metformin dose",
        "alpha-glucosidase inhibitor dose",
        "smoking status",
        "systolic blood pressure",
        "diastolic blood pressure",
        "history of hypoglycaemia",
        "history of diabetic complications"
      ]
    }
  }
}